These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 32840881)

  • 1. Chromatin regulators in retinoblastoma: Biological roles and therapeutic applications.
    Lee C; Kim JK
    J Cell Physiol; 2021 Apr; 236(4):2318-2332. PubMed ID: 32840881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatin remodelers HELLS and UHRF1 mediate the epigenetic deregulation of genes that drive retinoblastoma tumor progression.
    Benavente CA; Finkelstein D; Johnson DA; Marine JC; Ashery-Padan R; Dyer MA
    Oncotarget; 2014 Oct; 5(20):9594-608. PubMed ID: 25338120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etiology including epigenetic defects of retinoblastoma.
    Zhou L; Tong Y; Ho BM; Li J; Chan HYE; Zhang T; Du L; He JN; Chen LJ; Tham CC; Yam JC; Pang CP; Chu WK
    Asia Pac J Ophthalmol (Phila); 2024; 13(3):100072. PubMed ID: 38789041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UHRF1 downmodulation enhances antitumor effects of histone deacetylase inhibitors in retinoblastoma by augmenting oxidative stress-mediated apoptosis.
    Kim JK; Kan G; Mao Y; Wu Z; Tan X; He H; Lee C
    Mol Oncol; 2020 Feb; 14(2):329-346. PubMed ID: 31782885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting the Transcriptional and Chromatin Accessibility Heterogeneity of Proliferating Cone Precursors in Human Retinoblastoma Tumors by Single Cell Sequencing-Opening Pathways to New Therapeutic Strategies?
    Collin J; Queen R; Zerti D; Steel DH; Bowen C; Parulekar M; Lako M
    Invest Ophthalmol Vis Sci; 2021 May; 62(6):18. PubMed ID: 34003213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and pharmacologic targeting of EZH2, a fetal retinal protein and epigenetic regulator, in human retinoblastoma.
    Khan M; Walters LL; Li Q; Thomas DG; Miller JM; Zhang Q; Sciallis AP; Liu Y; Dlouhy BJ; Fort PE; Archer SM; Demirci H; Dou Y; Rao RC
    Lab Invest; 2015 Nov; 95(11):1278-90. PubMed ID: 26280220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic regulation of human retinoblastoma.
    Singh U; Malik MA; Goswami S; Shukla S; Kaur J
    Tumour Biol; 2016 Nov; 37(11):14427-14441. PubMed ID: 27639385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RB protein family in retinal development and retinoblastoma: new insights from new mouse models.
    Bremner R; Chen D; Pacal M; Livne-Bar I; Agochiya M
    Dev Neurosci; 2004; 26(5-6):417-34. PubMed ID: 15855771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-cancer molecular analysis of the RB tumor suppressor pathway.
    Knudsen ES; Nambiar R; Rosario SR; Smiraglia DJ; Goodrich DW; Witkiewicz AK
    Commun Biol; 2020 Apr; 3(1):158. PubMed ID: 32242058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA hypermethylation/boundary control loss identified in retinoblastomas associated with genetic and epigenetic inactivation of the
    Raizis AM; Racher HM; Foucal A; Dimaras H; Gallie BL; George PM
    Epigenetics; 2021 Sep; 16(9):940-954. PubMed ID: 33258708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-98 targets HMGA2 to inhibit the development of retinoblastoma through mediating Wnt/β-catenin pathway.
    Li W; Wang J; Zhang D; Zhang X; Xu J; Zhao L
    Cancer Biomark; 2019; 25(1):79-88. PubMed ID: 31033463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive identification of pathogenic variants in retinoblastoma by long- and short-read sequencing.
    Zheng J; Li T; Ye H; Jiang Z; Jiang W; Yang H; Wu Z; Xie Z
    Cancer Lett; 2024 Aug; 598():217121. PubMed ID: 39009069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability in retinoblastoma genome stability is driven by age and not heritability.
    Polski A; Xu L; Prabakar RK; Gai X; Kim JW; Shah R; Jubran R; Kuhn P; Cobrinik D; Hicks J; Berry JL
    Genes Chromosomes Cancer; 2020 Oct; 59(10):584-590. PubMed ID: 32390242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB.
    Betz BL; Strobeck MW; Reisman DN; Knudsen ES; Weissman BE
    Oncogene; 2002 Aug; 21(34):5193-203. PubMed ID: 12149641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translating RB1 predictive value in clinical cancer therapy: Are we there yet?
    Indovina P; Pentimalli F; Conti D; Giordano A
    Biochem Pharmacol; 2019 Aug; 166():323-334. PubMed ID: 31176618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum of germline
    Rojanaporn D; Boontawon T; Chareonsirisuthigul T; Thanapanpanich O; Attaseth T; Saengwimol D; Anurathapan U; Sujirakul T; Kaewkhaw R; Hongeng S
    Mol Vis; 2018; 24():778-788. PubMed ID: 30636860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma.
    Ewens KG; Bhatti TR; Moran KA; Richards-Yutz J; Shields CL; Eagle RC; Ganguly A
    Cancer Med; 2017 Mar; 6(3):619-630. PubMed ID: 28211617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De-regulated expression of the BRG1 chromatin remodeling factor in bone marrow mesenchymal stromal cells induces senescence associated with the silencing of NANOG and changes in the levels of chromatin proteins.
    Squillaro T; Severino V; Alessio N; Farina A; Di Bernardo G; Cipollaro M; Peluso G; Chambery A; Galderisi U
    Cell Cycle; 2015; 14(8):1315-26. PubMed ID: 25724006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rb suppresses human cone-precursor-derived retinoblastoma tumours.
    Xu XL; Singh HP; Wang L; Qi DL; Poulos BK; Abramson DH; Jhanwar SC; Cobrinik D
    Nature; 2014 Oct; 514(7522):385-8. PubMed ID: 25252974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic instability and proliferation/survival pathways in RB1-deficient malignancies.
    Pappas L; Xu XL; Abramson DH; Jhanwar SC
    Adv Biol Regul; 2017 May; 64():20-32. PubMed ID: 28242412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.